Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666715

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666715

Infant Formula DHA Algae Oil Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 235 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Infant Formula DHA Algae Oil Market was valued at USD 367.2 million in 2024, with projections indicating a robust CAGR of 7% from 2025 to 2034. This growth can be largely attributed to a growing awareness of the numerous health benefits associated with DHA, a crucial omega-3 fatty acid. As consumers continue to prioritize healthier dietary choices, products enriched with DHA, such as infant formulas, dietary supplements, and functional foods, are rapidly gaining popularity. Parents are particularly keen on ensuring optimal brain and vision development for their children, leading to a surge in demand for DHA-enriched products. Furthermore, the increasing availability of plant-based DHA sources, particularly algae oil, has further driven consumer interest, as it aligns with the growing trend of sustainability and environmental consciousness. This preference for plant-based DHA, alongside advancements in oil extraction technology, ensures the market's continued expansion.

Infant Formula DHA Algae Oil Market - IMG1

The DHA algae oil market is segmented by DHA concentration into two primary categories: 30%-40% and 40%-50%. The 40%-50% concentration segment is the largest, generating USD 122.5 million in 2024. It is also the fastest-growing segment, with an increasing number of parents opting for formulas with higher DHA content. This demand is driven by a stronger recognition of DHA's vital role in cognitive, visual, and immune system health, particularly during the early stages of a child's development. Parents are more informed than ever, making conscious decisions to provide their children with the most effective nutritional support possible.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$367.2 Million
Forecast Value$734.8 Million
CAGR7%

Market segmentation also includes age groups such as 0-3 years, 3-6 years, and other groups, which include premature infants and older children. The 0-3 years segment dominated the market with a share of 96.9% in 2024, and it continues to see the fastest growth. Infants and toddlers have specific nutritional needs that are crucial for brain development, visual health, and immune system strengthening. DHA-enriched formulas play an integral role in meeting these needs, and as awareness of these benefits increases, the demand for DHA-infused infant formulas is set to soar.

In the U.S., the market for DHA algae oil in infant formulas accounted for USD 22.3 million in 2024. This growth is supported by regulatory frameworks, such as recommendations from the FDA and WHO, which require the inclusion of DHA in infant formulas. Additionally, parents' growing understanding of DHA's importance in early childhood development has led to increased adoption of premium formulas. High disposable income levels, coupled with well-established distribution channels, including e-commerce, have made these products more accessible to American consumers.

Product Code: 4832

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Growing demand for breast milk substitutes
      • 3.6.1.2 Favorable regulatory outlook
      • 3.6.1.3 Significant expansion of the baby food industry
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Price volatility of raw material
      • 3.6.2.2 Contradictory scientific evidence of DHA benefits in infants
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Content, 2021-2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 30% - 40%
  • 5.3 40% - 50%

Chapter 6 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 0 – 3 years old
  • 6.3 3 – 6 years old
  • 6.4 Others (premature infants, 7+ years old)

Chapter 7 Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 UK
    • 7.3.2 Germany
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Algarithm
  • 8.2 Cellana
  • 8.3 Far East Microalgae
  • 8.4 Goerlich Pharma
  • 8.5 Guangdong Runke Bio-Engineering
  • 8.6 Henry Lamotte OILS
  • 8.7 Hubei Fuxing Biotechnology
  • 8.8 JC Biotech
  • 8.9 Kingdomway Nutrition
  • 8.10 Lonza
  • 8.11 Meteoric Biopharmaceutical
  • 8.12 Nordic Naturals
  • 8.13 Polaris
  • 8.14 Qingdao Keyuan Marine Biochemistry
  • 8.15 Xiamen Huison Biotech
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!